SARS-CoV-2 antibody seroprevalence in Tbilisi, the capital city of country of Georgia
Tengiz Tsertsvadze, Lana Gatserelia, Marine Mirziashvili, Natia Dvali, Akaki Abutidze, Revaz Metchurtchlishvili, Carlos el Rio, View ORCID ProfileNikoloz Chkhartishvili
doi: https://doi.org/10.1101/2020.09.18.20195024
Tengiz Tsertsvadze
1Infectious Diseases, AIDS and Clinical Immunology Research Center, Tbilisi, Georgia
2Ivane Javakhishvili Tbilisi State University, Tbilisi, Georgia
MD, PhDLana Gatserelia
1Infectious Diseases, AIDS and Clinical Immunology Research Center, Tbilisi, Georgia
PhDMarine Mirziashvili
1Infectious Diseases, AIDS and Clinical Immunology Research Center, Tbilisi, Georgia
RNNatia Dvali
1Infectious Diseases, AIDS and Clinical Immunology Research Center, Tbilisi, Georgia
3Caucasus International University, Tbilisi, Georgia
MD, PhDAkaki Abutidze
1Infectious Diseases, AIDS and Clinical Immunology Research Center, Tbilisi, Georgia
2Ivane Javakhishvili Tbilisi State University, Tbilisi, Georgia
MD, MPH, PhDRevaz Metchurtchlishvili
1Infectious Diseases, AIDS and Clinical Immunology Research Center, Tbilisi, Georgia
MDCarlos el Rio
4Emory University, Atlanta, GA, USA
MDNikoloz Chkhartishvili
1Infectious Diseases, AIDS and Clinical Immunology Research Center, Tbilisi, Georgia
3Caucasus International University, Tbilisi, Georgia
MD, MS, PhD
Data Availability
Data availability is restricted in accordance with national laws and regulations. Data are available from the Infectious Diseases, AIDS and Clinical Immunology Research Center for qualifying researchers. Data requests can be made at aids{at}aidscenter.ge.
Posted September 18, 2020.
SARS-CoV-2 antibody seroprevalence in Tbilisi, the capital city of country of Georgia
Tengiz Tsertsvadze, Lana Gatserelia, Marine Mirziashvili, Natia Dvali, Akaki Abutidze, Revaz Metchurtchlishvili, Carlos el Rio, Nikoloz Chkhartishvili
medRxiv 2020.09.18.20195024; doi: https://doi.org/10.1101/2020.09.18.20195024
SARS-CoV-2 antibody seroprevalence in Tbilisi, the capital city of country of Georgia
Tengiz Tsertsvadze, Lana Gatserelia, Marine Mirziashvili, Natia Dvali, Akaki Abutidze, Revaz Metchurtchlishvili, Carlos el Rio, Nikoloz Chkhartishvili
medRxiv 2020.09.18.20195024; doi: https://doi.org/10.1101/2020.09.18.20195024
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (668)
- Allergy and Immunology (668)
- Anesthesia (181)
- Cardiovascular Medicine (2648)
- Dermatology (223)
- Emergency Medicine (399)
- Epidemiology (12228)
- Forensic Medicine (10)
- Gastroenterology (759)
- Genetic and Genomic Medicine (4103)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2657)
- Health Policy (1005)
- Hematology (363)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (436)
- Neurology (3882)
- Nursing (209)
- Nutrition (577)
- Oncology (2030)
- Ophthalmology (585)
- Orthopedics (240)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1115)
- Primary Care Research (452)
- Public and Global Health (6527)
- Radiology and Imaging (1403)
- Respiratory Medicine (871)
- Rheumatology (409)
- Sports Medicine (342)
- Surgery (448)
- Toxicology (53)
- Transplantation (185)
- Urology (165)